Core Viewpoint - InSilico Medicine, a leading AI pharmaceutical company from Yixing, officially listed on the Hong Kong Stock Exchange, marking a significant milestone in its capital market journey and showcasing Yixing's strategic investment in emerging industries [1] Group 1: Company Overview - InSilico Medicine is the 8th company from Yixing to be listed on the Hong Kong Stock Exchange, making Yixing the city with the highest number of listed companies in Wuxi, increasing the total number of listed companies in the city to 20 [3] - The company issued shares at a price of HKD 24.05 per share, planning to issue 94.69 million shares, with an expected fundraising of approximately HKD 2.277 billion, which will be the largest biotech IPO in the Hong Kong market in 2025 [6] Group 2: Use of Proceeds - The funds raised will be used to enhance the AI platform and automate laboratory construction, accelerating the research and development of new molecules, mechanisms, and targets across multiple disease areas, contributing to the digital transformation of the global pharmaceutical industry [6] Group 3: Innovation and Patents - Currently, InSilico Medicine holds 787 patents and patent applications, with over 30 self-developed innovative drug projects, of which 10 have received clinical trial approval [7] - The world's first AI-assisted discovery of a new target and AI-assisted design of an anti-idiopathic pulmonary fibrosis drug, Rentosertib, has completed Phase 2a clinical trials in China with positive results [7] Group 4: Strategic Initiatives - Yixing has consistently focused on company listings as a key strategy to create new engines, reconstruct new dynamics, and enhance new advantages, closely aligning with the city's "3+3+N" modern industrial cluster development [8] - A partnership was established between the municipal state-owned assets group and Xichuang Investment to jointly lead a USD 123 million financing round for InSilico Medicine, creating a platform that integrates "fund + enterprise + project" to drive deep integration of innovation and industry chains [10]
宜兴企业，港交所鸣锣上市！